Abivax raises €130m in ABB amidst flurry of pharma deals

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Equity
ABBs-Block Trades

Abivax raises €130m in ABB amidst flurry of pharma deals

Victoria Thiele
February 23, 2023 05:39 pm
blue DNA strand. Image shot 09/2020. Exact date unknown.

Rise of mRNA technology was a gamechanger for the sector, says analyst

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

ABBs-Block TradesFranceEquityHealth and Biotech
VT
Victoria Thiele
Senior Reporter - CLOs
Contact
Gift this article